Shimoda Masafumi, Tanaka Yoshiaki, Morimoto Kozo, Okumura Masao, Shimoda Kiyomi, Takemura Tamiko, Oka Teruaki, Yoshiyama Takashi, Yoshimori Kozo, Ohta Ken
Respiratory Disease Center.
Department of Thoracic Surgery, Fukujuji Hospital, Japan Anti-tuberculosis Association, Kiyose City, Tokyo.
Medicine (Baltimore). 2021 Mar 19;100(11):e25162. doi: 10.1097/MD.0000000000025162.
Levels of pleural fluid adenosine deaminase (ADA), a useful marker for the diagnosis of tuberculous pleurisy, are elevated in some reports of immunoglobulin G4 (IgG4)-related pleural effusion. We describe a patient with IgG4-related pleural effusion who exhibited a high concentration of ADA. Furthermore, we reviewed the literature to compare patients with IgG4-related pleural effusion and tuberculous pleurisy.
A 75-year-old male patient had dyspnea for 1 month with a left pleural effusion that was exudative, lymphocyte dominant. The pleural fluid test results revealed a total protein (TP) concentration of 6.60 g/dl, a lactate dehydrogenase (LDH) level of 383 IU/dl, and an ADA concentration of 54.5 U/L. An interferon gamma release assay showed a negative result.
Histological analysis of the thoracoscopic pleural biopsy revealed lymphoplasmacytic infiltration, with 80 IgG4-positive plasma cells/high-power field, and an IgG4/IgG ratio of approximately 40% to 50%. Other diseases were ruled out based on symptoms, negative autoimmune antigen results, and histopathologic findings. Thus, he was diagnosed with IgG4-related pleural effusion.
He received 15 mg of prednisolone as therapy.
His pleural effusion and symptoms improved gradually within several months, and prednisolone was tapered to 6 mg daily.
It is important to distinguish between IgG4-related pleural effusion and tuberculous pleurisy. Therefore, we compared 22 patients with IgG4-related pleural effusion from PubMed and the Japan Medical Abstracts Society to 40 patients with tuberculous pleurisy at Fukujuji Hospital from January 2017 to May 2019. According to thoracentesis findings, 14 of 18 patients with IgG4-related pleural effusion had high ADA more than 40 U/L. The pleural effusion of patients with IgG4-related pleural effusion showed higher TP levels (P < .001) and lower LDH (P < .001) and ADA levels (P = .002) than those with tuberculous pleurisy. Moreover, the pleural fluid ADA/TP ratio was a good predictor for differentiating IgG4-related pleural effusion and tuberculous pleurisy (area under the receiver operating characteristic curve of 0.909; 95% confidence level: 0.824-0.994).
在一些免疫球蛋白G4(IgG4)相关胸腔积液的报告中,胸腔积液腺苷脱氨酶(ADA)水平升高,ADA是诊断结核性胸膜炎的有用标志物。我们描述了一名ADA浓度高的IgG4相关胸腔积液患者。此外,我们回顾了文献以比较IgG4相关胸腔积液患者和结核性胸膜炎患者。
一名75岁男性患者呼吸困难1个月,伴有左侧胸腔积液,为渗出液,以淋巴细胞为主。胸腔积液检测结果显示总蛋白(TP)浓度为6.60g/dl,乳酸脱氢酶(LDH)水平为383IU/dl,ADA浓度为54.5U/L。干扰素γ释放试验结果为阴性。
胸腔镜胸膜活检的组织学分析显示淋巴细胞浆细胞浸润,每高倍视野有80个IgG4阳性浆细胞,IgG4/IgG比率约为40%至50%。根据症状、自身免疫抗原阴性结果和组织病理学发现排除了其他疾病。因此,他被诊断为IgG4相关胸腔积液。
他接受了15mg泼尼松龙治疗。
他的胸腔积液和症状在几个月内逐渐改善,泼尼松龙逐渐减量至每日6mg。
区分IgG4相关胸腔积液和结核性胸膜炎很重要。因此,我们将来自PubMed和日本医学摘要协会的22例IgG4相关胸腔积液患者与2017年1月至2019年5月在福住寺医院的40例结核性胸膜炎患者进行了比较。根据胸腔穿刺结果,18例IgG4相关胸腔积液患者中有14例ADA高于40U/L。与结核性胸膜炎患者相比,IgG4相关胸腔积液患者的胸腔积液TP水平更高(P<0.001),LDH(P<0.001)和ADA水平更低(P = 0.002)。此外,胸腔积液ADA/TP比率是区分IgG4相关胸腔积液和结核性胸膜炎的良好预测指标(受试者操作特征曲线下面积为0.909;95%置信区间:0.824 - 0.994)。